NTRA Natera, Inc.
Nasdaq · SEC CIK 1604821 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $376.04M 134 sales by 12 insiders
- Filings on record
- 782 since 2021-07-07, latest 2026-09-18 21:35
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Rabinowitz Matthew | EXECUTIVE COB, Dir | — | $124.05M |
| Chapman Steven Leonard | CEO AND Pres, Dir | — | $93.95M |
| BOTHA ROELOF | Dir | — | $34.89M |
| RABINOWITZ DANIEL | SEC. AND CLO | — | $23.83M |
| Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | — | $22.88M |
| Sheena Jonathan | Dir, CO-FOUNDER | — | $22.83M |
| Brophy Michael Burkes | CFO | — | $22.14M |
| ROSENMAN HERM | Dir | — | $15.14M |
| Fesko John | Pres, CHIEF BUS. Off | — | $9.35M |
| Baynes Roy D. | Dir | — | $2.81M |
Transactions 1,058
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-22 | 2025-10-21 | NTRA | Fesko John | Pres, CHIEF BUS. Off | S - Sale | $187.95 | -339 | 152.4K | -0.2% | -$63.7K | |
| D | 2025-10-22 | 2025-10-20 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | M - OptEx | — | +856 | 204.2K | +0.4% | — |
| D | 2025-10-22 | 2025-10-21 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale+OE | $187.95 | -464 | 203.7K | -0.2% | -$87.2K |
| 2025-10-22 | 2025-10-21 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $187.95 | -292 | 117.3K | -0.2% | -$54.9K | |
| D | 2025-10-22 | 2025-10-20 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | M - OptEx | — | +3,386 | 157.5K | +2% | — |
| D | 2025-10-22 | 2025-10-21 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale+OE | $187.95 | -1,603 | 155.9K | -1% | -$301.3K |
| I | 2025-10-22 | 2025-10-20 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | S - Sale | $190.00 | -10.0K | 5,000 | -67% | -$1.90M |
| MI | 2025-10-17 | 2025-10-17 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $178.91 | -1,500 | 28.0K | -5% | -$268.4K |
| M | 2025-10-17 | 2025-10-15 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $175.47 | -3,070 | 236.1K | -1% | -$538.7K |
| D | 2025-10-01 | 2025-09-29 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | M - OptEx | — | +2,500 | 204.7K | +1% | — |
| D | 2025-10-01 | 2025-09-30 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale+OE | $162.05 | -1,364 | 203.3K | -0.7% | -$221.0K |
| D | 2025-10-01 | 2025-09-30 | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $162.05 | -2,491 | 69.2K | -3% | -$403.7K |
| D | 2025-10-01 | 2025-09-29 | NTRA | Brophy Michael Burkes | CFO | M - OptEx | — | +6,250 | 71.7K | +10% | — |
| M | 2025-10-01 | 2025-10-01 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $159.99 | -3,000 | 117.6K | -2% | -$480.0K |
| DM | 2025-10-01 | 2025-09-30+ | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale+OE | $160.80 | -23.2K | 168.2K | -12% | -$3.73M |
| D | 2025-10-01 | 2025-09-29 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | M - OptEx | — | +18.8K | 177.3K | +12% | — |
| MI | 2025-09-22 | 2025-09-19 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $179.47 | -11.0K | 29.5K | -27% | -$1.97M |
| M | 2025-09-22 | 2025-09-17 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $175.94 | -3,070 | 239.4K | -1% | -$540.1K |
| M | 2025-09-19 | 2025-09-18+ | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | S - Sale | $180.41 | -40.0K | 2.32M | -2% | -$7.22M |
| I | 2025-09-19 | 2025-09-18 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | S - Sale | $180.00 | -10.0K | 15.0K | -40% | -$1.80M |
| 2025-09-17 | 2025-09-15 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | G - Gift | $0.00 | -300 | 120.6K | -0.2% | $0 | |
| MI | 2025-09-16 | 2025-09-12 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | S - Sale | $170.54 | -5,000 | 25.5K | -16% | -$852.7K |
| M | 2025-09-05 | 2025-09-02 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $166.53 | -5,079 | 161.9K | -3% | -$845.8K |
| M | 2025-09-05 | 2025-09-02 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $166.62 | -3,000 | 120.9K | -2% | -$499.9K |
| M | 2025-09-02 | 2025-06-27+ | NTRA | Chapman Rowan E | Dir | A - Grant | — | +2,563 | 8,765 | +41% | — |
| 2025-09-02 | 2025-08-28 | NTRA | Chapman Rowan E | Dir | S - Sale | $166.99 | -2,750 | 6,015 | -31% | -$459.2K | |
| M | 2025-08-15 | 2025-08-14 | NTRA | Fesko John | Pres, CHIEF BUS. Off | S - Sale | $155.46 | -678 | 152.7K | -0.4% | -$105.4K |
| 2025-08-15 | 2025-08-12 | NTRA | Fesko John | Pres, CHIEF BUS. Off | A - Grant | — | +1,675 | 153.4K | +1% | — | |
| M | 2025-08-15 | 2025-08-14 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $155.46 | -875 | 123.9K | -0.7% | -$136.0K |
| 2025-08-15 | 2025-08-12 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | A - Grant | — | +1,675 | 124.7K | +1% | — | |
| MI | 2025-08-12 | 2025-08-11 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $153.67 | -3,000 | 35.4K | -8% | -$461.0K |
| M | 2025-08-12 | 2025-08-08 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $161.90 | -3,070 | 245.2K | -1% | -$497.0K |
| M | 2025-08-05 | 2025-08-01 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $132.88 | -5,807 | 166.6K | -3% | -$771.7K |
| M | 2025-08-05 | 2025-08-01 | NTRA | Marcus Gail Boxer | Dir | S - Sale | $133.17 | -2,496 | 6,946 | -26% | -$332.4K |
| M | 2025-08-05 | 2025-08-01 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $132.88 | -3,000 | 123.1K | -2% | -$398.7K |
| M | 2025-07-30 | 2025-07-28+ | NTRA | Brophy Michael Burkes | CFO | S - Sale | $138.36 | -5,064 | 68.5K | -7% | -$700.7K |
| 2025-07-30 | 2025-07-28 | NTRA | Fesko John | Pres, CHIEF BUS. Off | S - Sale | $139.81 | -1,710 | 151.8K | -1% | -$239.1K | |
| 2025-07-30 | 2025-07-28 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale | $139.81 | -1,994 | 202.2K | -1.0% | -$278.8K | |
| 2025-07-30 | 2025-07-28 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $139.81 | -2,206 | 126.1K | -2% | -$308.4K | |
| 2025-07-30 | 2025-07-28 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | S - Sale | $139.81 | -1,718 | 2.36M | -0.1% | -$240.2K | |
| 2025-07-30 | 2025-07-28 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $139.81 | -6,092 | 169.4K | -3% | -$851.7K | |
| 2025-07-30 | 2025-07-28 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $139.81 | -479 | 245.3K | -0.2% | -$67.0K | |
| 2025-07-29 | 2025-07-25 | NTRA | Bertagnolli Monica | Dir | A - Grant | — | +108 | 5,128 | +2% | — | |
| 2025-07-29 | 2025-07-25 | NTRA | Williams Brinkley Ruth | Dir | A - Grant | — | +112 | 5,219 | +2% | — | |
| 2025-07-29 | 2025-07-25 | NTRA | Baynes Roy D. | Dir | A - Grant | — | +108 | 18.3K | +0.6% | — | |
| 2025-07-29 | 2025-07-25 | NTRA | ROSENMAN HERM | Dir | A - Grant | — | +153 | 68.6K | +0.2% | — | |
| 2025-07-29 | 2025-07-25 | NTRA | Marcus Gail Boxer | Dir | A - Grant | — | +141 | 8,259 | +2% | — | |
| 2025-07-29 | 2025-07-25 | NTRA | BOTHA ROELOF | Dir | A - Grant | — | +173 | 6,690 | +3% | — | |
| DM | 2025-07-24 | 2025-07-22+ | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $139.94 | -2,170 | 70.5K | -3% | -$303.7K |
| D | 2025-07-24 | 2025-07-22 | NTRA | Brophy Michael Burkes | CFO | M - OptEx | — | +1,250 | 71.7K | +2% | — |
| D | 2025-07-22 | 2025-07-20 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | M - OptEx | — | +190 | 245.9K | +0.1% | — |
| D | 2025-07-22 | 2025-07-21 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale+OE | $139.29 | -93 | 245.8K | -0.0% | -$13.0K |
| M | 2025-07-22 | 2025-05-27+ | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $154.22 | -1,940 | 128.6K | -1% | -$299.2K |
| DM | 2025-07-22 | 2025-06-18+ | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale+OE | $169.79 | -20.4K | 213.7K | -9% | -$3.46M |
| D | 2025-07-22 | 2025-07-20 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | M - OptEx | — | +856 | 204.6K | +0.4% | — |
| M | 2025-07-22 | 2025-05-27+ | NTRA | Fesko John | Pres, CHIEF BUS. Off | S - Sale | $153.50 | -1,777 | 153.5K | -1% | -$272.8K |
| D | 2025-07-22 | 2025-07-20 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | M - OptEx | — | +3,386 | 177.1K | +2% | — |
| D | 2025-07-22 | 2025-07-21 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale+OE | $139.29 | -1,622 | 175.5K | -0.9% | -$225.9K |
| D | 2025-07-22 | 2025-07-20 | NTRA | Brophy Michael Burkes | CFO | M - OptEx | — | +1,522 | 72.0K | +2% | — |
| D | 2025-07-22 | 2025-07-21 | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $139.29 | -602 | 71.4K | -0.8% | -$83.9K |
| 2025-07-18 | 2025-07-16 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $149.96 | -3,070 | 245.7K | -1% | -$460.4K | |
| M | 2025-07-03 | 2025-07-01 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $166.77 | -3,000 | 132.6K | -2% | -$500.3K |
| DM | 2025-07-03 | 2025-07-01 | NTRA | Marcus Gail Boxer | Dir | S - Sale+OE | $167.36 | -4,299 | 8,118 | -35% | -$719.5K |
| D | 2025-07-03 | 2025-07-01 | NTRA | Marcus Gail Boxer | Dir | M - OptEx | $24.42 | +4,299 | 12.4K | +53% | +$105.0K |
| MI | 2025-07-03 | 2025-07-02 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $160.11 | -3,000 | 37.1K | -7% | -$480.3K |
| M | 2025-07-03 | 2025-07-01 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $166.53 | -5,343 | 177.6K | -3% | -$889.8K |
| 2025-07-01 | 2025-06-27 | NTRA | Williams Brinkley Ruth | Dir | A - Grant | — | +2,143 | 5,107 | +72% | — | |
| M | 2025-07-01 | 2025-06-27 | NTRA | Marcus Gail Boxer | Dir | A - Grant | — | +2,414 | 7,847 | +44% | — |
| M | 2025-07-01 | 2025-06-27 | NTRA | BOTHA ROELOF | Dir | A - Grant | — | +2,414 | 6,246 | +63% | — |
| M | 2025-07-01 | 2025-06-27 | NTRA | ROSENMAN HERM | Dir | A - Grant | — | +2,414 | 68.5K | +4% | — |
| 2025-07-01 | 2025-06-27 | NTRA | Bertagnolli Monica | Dir | A - Grant | — | +2,143 | 5,020 | +74% | — | |
| 2025-07-01 | 2025-06-27 | NTRA | Baynes Roy D. | Dir | A - Grant | — | +2,143 | 18.2K | +13% | — | |
| MI | 2025-06-20 | 2025-06-16 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $164.55 | -3,000 | 38.4K | -7% | -$493.7K |
| 2025-06-20 | 2025-06-18 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $167.29 | -3,070 | 248.8K | -1% | -$513.6K | |
| MI | 2025-06-20 | 2025-05-15+ | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | S - Sale | $155.26 | -54.0K | 30.0K | -64% | -$8.38M |
| M | 2025-06-11 | 2025-06-10 | NTRA | Marcus Gail Boxer | Dir | S - Sale | $164.44 | -4,000 | 6,304 | -39% | -$657.8K |
| M | 2025-06-04 | 2025-06-02 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $157.07 | -3,000 | 133.8K | -2% | -$471.2K |
| M | 2025-06-04 | 2025-06-02 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $157.11 | -6,111 | 180.5K | -3% | -$960.1K |
| M | 2025-05-13 | 2025-05-09 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $160.22 | -3,070 | 251.9K | -1% | -$491.9K |
| MI | 2025-05-13 | 2025-05-12 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $158.26 | -3,000 | 38.8K | -7% | -$474.8K |
| D | 2025-05-02 | 2025-05-01 | NTRA | Marcus Gail Boxer | Dir | M - OptEx | $24.42 | +4,000 | 13.7K | +41% | +$97.7K |
| DM | 2025-05-02 | 2025-05-01 | NTRA | Marcus Gail Boxer | Dir | S - Sale+OE | $151.61 | -4,000 | 9,704 | -29% | -$606.4K |
| M | 2025-05-02 | 2025-05-01 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $150.12 | -3,000 | 137.4K | -2% | -$450.4K |
| M | 2025-05-02 | 2025-05-01 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $150.10 | -6,980 | 185.2K | -4% | -$1.05M |
| 2025-04-30 | 2025-04-28 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | G - Gift | $0.00 | -75 | 139.2K | -0.1% | $0 | |
| 2025-04-30 | 2025-04-28 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $152.18 | -2,206 | 139.3K | -2% | -$335.7K | |
| 2025-04-30 | 2025-04-28 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $152.18 | -439 | 254.9K | -0.2% | -$66.8K | |
| M | 2025-04-30 | 2025-04-28+ | NTRA | Brophy Michael Burkes | CFO | S - Sale | $153.38 | -5,063 | 72.1K | -7% | -$776.6K |
| 2025-04-30 | 2025-04-28 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale | $152.18 | -1,993 | 223.7K | -0.9% | -$303.3K | |
| 2025-04-30 | 2025-04-28 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | S - Sale | $152.18 | -1,718 | 2.36M | -0.1% | -$261.4K | |
| 2025-04-30 | 2025-04-28 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $152.18 | -6,203 | 192.2K | -3% | -$944.0K | |
| 2025-04-30 | 2025-04-28 | NTRA | Fesko John | Pres, CHIEF BUS. Off | S - Sale | $152.18 | -1,709 | 155.2K | -1% | -$260.1K | |
| 2025-04-29 | 2025-04-25 | NTRA | Baynes Roy D. | Dir | A - Grant | — | +116 | 16.0K | +0.7% | — | |
| 2025-04-29 | 2025-04-25 | NTRA | ROSENMAN HERM | Dir | A - Grant | — | +164 | 66.1K | +0.2% | — | |
| 2025-04-29 | 2025-04-25 | NTRA | BOTHA ROELOF | Dir | A - Grant | — | +185 | 4,103 | +5% | — | |
| 2025-04-29 | 2025-04-25 | NTRA | HEALY JAMES | Dir | A - Grant | — | +142 | 46.3K | +0.3% | — | |
| DM | 2025-04-24 | 2025-04-22+ | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $148.92 | -2,161 | 75.6K | -3% | -$321.8K |
| D | 2025-04-24 | 2025-04-22 | NTRA | Brophy Michael Burkes | CFO | M - OptEx | — | +1,250 | 76.8K | +2% | — |
| DM | 2025-04-22 | 2025-04-21 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale+OE | $145.55 | -86 | 255.4K | -0.0% | -$12.5K |
| D | 2025-04-22 | 2025-04-20 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | M - OptEx | — | +190 | 255.4K | +0.1% | — |
Purchase Sale Sale after option exercise All abbreviations